Top

Published in:

01-02-2016 | Review Article

Circulating Progenitor Cells and Childhood Cardiovascular Disease

Authors: Eric J. Kort, Lacey Croskey, Taryn Scibienski, Surender Rajasekaran, Stefan Jovinge

Published in: Pediatric Cardiology | Issue 2/2016

Abstract

Circulating progenitor cells have been extensively studied in the context of heart disease in adults. In these patients, they have been demonstrated to be markers of myocardial injury and recovery as well as potential therapeutic agents. However, studies in children are much more limited. Here we review current knowledge pertaining to circulating progenitor cells in the context of childhood cardiovascular disease. Priorities for further research are also highlighted.

Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964–967CrossRefPubMed

Bui KC, Senadheera D, Wang X, Hendrickson B, Friedlich P, Lutzko C (2010) Recovery of multipotent progenitors from the peripheral blood of patients requiring extracorporeal membrane oxygenation support. Am J Respir Crit Care Med 181(3):226–237CrossRefPubMed

Cabanelas N, Martins JD, Pinto F (2014) Initial use of endothelial progenitor cells capturing stents in paediatric congenital heart disease. Cardiol Young 24(5):900–904CrossRefPubMed

Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, Bhavsar JR, Yoder MC, Haneline LS, Ingram DA (2007) Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 35(7):1109–1118CrossRefPubMed

Cebotari S, Lichtenberg A, Tudorache I, Hilfiker A, Mertsching H, Leyh R, Breymann T, Kallenbach K, Maniuc L, Batrinac A, Repin O, Maliga O, Ciubotaru A, Haverich A (2006) Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 114(1 Suppl):I132–I137PubMed

Chen ZZ, Jiang XD, Zhang LL, Shang JH, Du MX, Xu G, Xu RX (2008) Beneficial effect of autologous transplantation of bone marrow stromal cells and endothelial progenitor cells on cerebral ischemia in rabbits. Neurosci Lett 445(1):36–41CrossRefPubMed

Choi YH, Neef K, Reher M, Liakopoulos OJ, Zeriouh M, Wittwer T, Stamm C, Madershahian N, Teschendorf P, Wahlers T (2010) The influence of pre-operative risk on the number of circulating endothelial progenitor cells during cardiopulmonary bypass. Cytotherapy 12(1):79–87CrossRefPubMed

Clarke LA, Hong Y, Eleftheriou D, Shah V, Arrigoni F, Klein NJ, Brogan PA (2010) Endothelial injury and repair in systemic vasculitis of the young. Arthritis Rheum 62(6):1770–1780CrossRefPubMed

Cordina RL, Nakhla S, O’Meagher S, Leaney J, Graham S, Celermajer DS (2015) Widespread endotheliopathy in adults with cyanotic congenital heart disease. Cardiol Young 25(3):511–519CrossRefPubMed

10.

Dobert N, Britten M, Assmus B, Berner U, Menzel C, Lehmann R, Hamscho N, Schachinger V, Dimmeler S, Zeiher AM, Grunwald F (2004) Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT. Eur J Nucl Med Mol Imaging 31(8):1146–1151CrossRefPubMed

11.

Dubois C, Liu X, Claus P, Marsboom G, Pokreisz P, Vandenwijngaert S, Depelteau H, Streb W, Chaothawee L, Maes F, Gheysens O, Debyser Z, Gillijns H, Pellens M, Vandendriessche T, Chuah M, Collen D, Verbeken E, Belmans A, Van de Werf F, Bogaert J, Janssens S (2010) Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction. J Am Coll Cardiol 55(20):2232–2243CrossRefPubMed

12.

Erdbruegger U, Dhaygude A, Haubitz M, Woywodt A (2010) Circulating endothelial cells: markers and mediators of vascular damage. Curr Stem Cell Res Ther 5(4):294–302CrossRefPubMed

13.

Flores-Ramirez R, Uribe-Longoria A, Rangel-Fuentes MM, Gutierrez-Fajardo P, Salazar-Riojas R, Cervantes-Garcia D, Trevino-Ortiz JH, Benavides-Chereti GJ, Espinosa-Oliveros LP, Limon-Rodriguez RH, Monreal-Puente R, Gonzalez-Trevino JL, Rojas-Martinez A (2010) Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency. Cardiovasc Revasc Med 11(2):72–78CrossRefPubMed

14.

Friedrich EB, Walenta K, Scharlau J, Nickenig G, Werner N (2006) CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 98(3):e20–e25CrossRefPubMed

15.

George J, Shmilovich H, Deutsch V, Miller H, Keren G, Roth A (2006) Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng 12(2):331–335CrossRefPubMed

16.

Groner JA, Huang H, Nagaraja H, Kuck J, Bauer JA (2015) Secondhand smoke exposure and endothelial stress in children and adolescents. Acad Pediatr 15(1):54–60CrossRefPubMed

17.

He T, Smith LA, Harrington S, Nath KA, Caplice NM, Katusic ZS (2004) Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 35(10):2378–2384CrossRefPubMed

18.

Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348(7):593–600CrossRefPubMed

19.

Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA (2001) Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Investig 107(11):1395–1402PubMedCentralCrossRefPubMed

20.

Jie KE, Lilien MR, Goossens MH, Westerweel PE, Klein MK, Verhaar MC (2010) Reduced endothelial progenitor cells in children with hemodialysis but not predialysis chronic kidney disease. Pediatrics 126(4):e990–e993CrossRefPubMed

21.

Kheirandish-Gozal L, Bhattacharjee R, Kim J, Clair HB, Gozal D (2010) Endothelial progenitor cells and vascular dysfunction in children with obstructive sleep apnea. Am J Respir Crit Care Med 182(1):92–97PubMedCentralCrossRefPubMed

22.

Kim JH, Jung JH, Phi JH, Kang HS, Kim JE, Chae JH, Kim SJ, Kim YH, Kim YY, Cho BK, Wang KC, Kim SK (2010) Decreased level and defective function of circulating endothelial progenitor cells in children with moyamoya disease. J Neurosci Res 88(3):510–518PubMed

23.

Kuliczkowski W, Derzhko R, Prajs I, Podolak-Dawidziak M, Serebruany VL (2012) Endothelial progenitor cells and left ventricle function in patients with acute myocardial infarction: potential therapeutic considertions. Am J Ther 19(1):44–50CrossRefPubMed

24.

Lau KK, Obeid J, Breithaupt P, Belostotsky V, Arora S, Nguyen T, Timmons BW (2015) Effects of acute exercise on markers of inflammation in pediatric chronic kidney disease: a pilot study. Pediatr Nephrol 30(4):615–621CrossRefPubMed

25.

Li CJ, Gaol RL, Yang YJ, Hu FH, Yang WX, You SJ, Song LF, Ruan YM, Qiao SB, Chen JL, Li JJ (2010) Effect of intracoronary infusion of bone marrow mononuclear cells or peripheral endothelial progenitor cells on myocardial ischemia-reperfusion injury in mini-swine. Chin Med Sci J 25(3):176–181CrossRefPubMed

26.

Liu JF, Du ZD, Chen Z, Lu DX, Li L, Guan YQ, Wan SG (2012) Endothelial progenitor cell down-regulation in a mouse model of Kawasaki disease. Chin Med J (Engl) 125(3):496–501

27.

Metsuyanim S, Levy R, Davidovits M, Dekel B (2009) Molecular evaluation of circulating endothelial progenitor cells in children undergoing hemodialysis and after kidney transplantation. Pediatr Res 65(2):221–225CrossRefPubMed

28.

Mohan S, Barsalou J, Bradley TJ, Slorach C, Reynolds JA, Hasni S, Thompson B, Ng L, Levy D, Silverman E, Kaplan MJ (2015) Endothelial progenitor cell phenotype and function are impaired in childhood-onset systemic lupus erythematosus. Arthritis Rheumatol 67(8):2257–2262CrossRefPubMed

29.

Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, Hescheler J, Taneera J, Fleischmann BK, Jacobsen SE (2004) Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10(5):494–501CrossRefPubMed

30.

Nygren JM, Liuba K, Breitbach M, Stott S, Thoren L, Roell W, Geisen C, Sasse P, Kirik D, Bjorklund A, Nerlov C, Fleischmann BK, Jovinge S, Jacobsen SE (2008) Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Nat Cell Biol 10(5):584–592CrossRefPubMed

31.

Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P (2003) Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transpl 7(Suppl 3):86–88CrossRef

32.

Ostadal B, Ostadalova I, Kolar F, Charvatova Z, Netuka I (2009) Ontogenetic development of cardiac tolerance to oxygen deprivation—possible mechanisms. Physiol Res 58(Suppl 2):S1–S12PubMed

33.

Park JH, Miyashita M, Kwon YC, Park HT, Kim EH, Park JK, Park KB, Yoon SR, Chung JW, Nakamura Y, Park SK (2012) A 12-week after-school physical activity programme improves endothelial cell function in overweight and obese children: a randomised controlled study. BMC Pediatr 12:111PubMedCentralCrossRefPubMed

34.

Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95(3):952–958PubMed

35.

Pham HP, Patel N, Semedei-Pomales M, Bhatia M, Schwartz J (2012) The use of plerixafor in hematopoietic progenitor cell collection in pediatric patients: a single center experience. Cytotherapy 14(4):467–472CrossRefPubMed

36.

Qi Y, Jiang Q, Chen C, Cao Y, Qian L (2013) Circulating endothelial progenitor cells decrease in infants with bronchopulmonary dysplasia and increase after inhaled nitric oxide. PLoS ONE 8(11):e79060PubMedCentralCrossRefPubMed

37.

Schleicher M, Wendel HP, Fritze O, Stock UA (2009) In vivo tissue engineering of heart valves: evolution of a novel concept. Regen Med 4(4):613–619CrossRefPubMed

38.

Schmidt D, Breymann C, Weber A, Guenter CI, Neuenschwander S, Zund G, Turina M, Hoerstrup SP (2004) Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts. Ann Thorac Surg 78(6):2094–2098CrossRefPubMed

39.

Schmidt D, Asmis LM, Odermatt B, Kelm J, Breymann C, Gossi M, Genoni M, Zund G, Hoerstrup SP (2006) Engineered living blood vessels: functional endothelia generated from human umbilical cord-derived progenitors. Ann Thorac Surg 82(4):1465–1471; discussion 1471

40.

Smadja DM, Gaussem P, Mauge L, Israel-Biet D, Dignat-George F, Peyrard S, Agnoletti G, Vouhe PR, Bonnet D, Levy M (2009) Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease. Circulation 119(3):374–381CrossRefPubMed

41.

Smadja DM, Mauge L, Gaussem P, d’Audigier C, Israel-Biet D, Celermajer DS, Bonnet D, Levy M (2011) Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension. Angiogenesis 14(1):17–27PubMedCentralCrossRefPubMed

42.

Sun Y, Yi D, Wang Y, Zheng R, Sun G, Wang J, Liu Y, Ren J, Wang Y, Zhang S, Gu C, Pei J (2009) Age-dependent mobilization of circulating endothelial progenitor cells in infants and young children undergoing cardiac surgery with cardiopulmonary bypass. Cytokine 47(3):206–213CrossRefPubMed

43.

Tatsumi T, Ashihara E, Yasui T, Matsunaga S, Kido A, Sasada Y, Nishikawa S, Hadase M, Koide M, Nakamura R, Irie H, Ito K, Matsui A, Matsui H, Katamura M, Kusuoka S, Matoba S, Okayama S, Horii M, Uemura S, Shimazaki C, Tsuji H, Saito Y, Matsubara H (2007) Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circ J 71(8):1199–1207CrossRefPubMed

44.

Timmermans F, Van Hauwermeiren F, De Smedt M, Raedt R, Plasschaert F, De Buyzere ML, Gillebert TC, Plum J, Vandekerckhove B (2007) Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 27(7):1572–1579CrossRefPubMed

45.

Van Vliet P, Wu SM, Zaffran S, Puceat M (2012) Early cardiac development: a view from stem cells to embryos. Cardiovasc Res 96(3):352–362PubMedCentralCrossRefPubMed

46.

Walther C, Gaede L, Adams V, Gelbrich G, Leichtle A, Erbs S, Sonnabend M, Fikenzer K, Korner A, Kiess W, Bruegel M, Thiery J, Schuler G (2009) Effect of increased exercise in school children on physical fitness and endothelial progenitor cells: a prospective randomized trial. Circulation 120(22):2251–2259CrossRefPubMed

47.

Wang XX, Zhang FR, Shang YP, Zhu JH, Xie XD, Tao QM, Chen JZ (2007) Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol 49(14):1566–1571CrossRefPubMed

48.

Weber B, Zeisberger SM, Hoerstrup SP (2011) Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth. Placenta 32(Suppl 4):S316–S319CrossRefPubMed

49.

Wei L, Zhu W, Xia L, Yang Y, Liu H, Shen J, Zhu J, Xu Y, Yang Z, Wang C (2013) Therapeutic effect of eNOS-transfected endothelial progenitor cells on hemodynamic pulmonary arterial hypertension. Hypertens Res 36(5):414–421CrossRefPubMed

50.

Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353(10):999–1007CrossRefPubMed

51.

Wilson JG, Liu KD, Zhuo H, Caballero L, McMillan M, Fang X, Cosgrove K, Vojnik R, Calfee CS, Lee JW, Rogers AJ, Levitt J, Wiener-Kronish J, Bajwa EK, Leavitt A, McKenna D, Thompson BT, Matthay MA (2015) Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med 3(1):24–32PubMedCentralCrossRefPubMed

52.

Witt V, Beiglbock E, Ritter R, Wurth M, Peters C, Ladenstein R, Gadner H, Fritsch G (2007) Performance of a new separator system for routine autologous hematopoietic progenitor cell collection in small children. J Clin Apher 22(6):306–313CrossRefPubMed

53.

Xu MG, Meng XC, Li BN, Liu C (2013) The circulating level of endothelial progenitor cells after transcatheter closure of congenital heart disease in children. Pediatr Cardiol 34(6):1344–1349CrossRefPubMed

54.

Yu Y, Flint AF, Mulliken JB, Wu JK, Bischoff J (2004) Endothelial progenitor cells in infantile hemangioma. Blood 103(4):1373–1375CrossRefPubMed

55.

Zen K, Okigaki M, Hosokawa Y, Adachi Y, Nozawa Y, Takamiya M, Tatsumi T, Urao N, Tateishi K, Takahashi T, Matsubara H (2006) Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response. J Mol Cell Cardiol 40(6):799–809CrossRefPubMed

56.

Zhao YD, Courtman DW, Deng Y, Kugathasan L, Zhang Q, Stewart DJ (2005) Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 96(4):442–450CrossRefPubMed

Title: Circulating Progenitor Cells and Childhood Cardiovascular Disease
Authors: Eric J. Kort
Lacey Croskey
Taryn Scibienski
Surender Rajasekaran
Stefan Jovinge
Publication date: 01-02-2016
Publisher: Springer US
Published in: Pediatric Cardiology / Issue 2/2016
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-015-1300-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The STEP trials

Springer Medicine

Circulating Progenitor Cells and Childhood Cardiovascular Disease

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2016

Prostaglandin Availability and Association with Outcomes for Infants with Congenital Heart Disease

Intravenous Hydration for Management of Medication-Resistant Orthostatic Intolerance in the Adolescent and Young Adult

Exercise Performance in Patients with D-Loop Transposition of the Great Arteries After Arterial Switch Operation: Long-Term Outcomes and Longitudinal Assessment

Erratum to: Accuracy of Blood Pressure-to-Height Ratio to Define Elevated Blood Pressure in Children and Adolescents: The CASPIAN-IV Study

Vasoactive Inotropic Score (VIS) as Biomarker of Short-Term Outcomes in Adolescents after Cardiothoracic Surgery

Longitudinal Assessment of Blood Pressure in School-Aged Children: A 3-Year Follow-Up Study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page